Effects of chemotherapeutics on organotypic corticostriatal slice cultures identified by a panel of fluorescent and immunohistochemical markers

Neurotoxicity Research

Volumn 22, Issue 1, 2012, Pages 43-58

  Nørregaard, Annette ^a   Jensen, Stine Skov ^a   Kolenda, Jesper ^a   Aaberg Jessen, Charlotte ^a   Christensen, Karina Garnier ^a   Jensen, Poul Henning ^b   Schrøder, Henrik Daa ^a   Kristensen, Bjarne Winther ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Chemotherapy; GFAP; MAP2; Organotypic; P25 ; Propidium iodide

Indexed keywords

ALKYLATING AGENT; EOSIN; FLUORESCENT DYE; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMATOXYLIN; IMATINIB; MICROTUBULE ASSOCIATED PROTEIN 2; NIMUSTINE; PARAFFIN; PROPIDIUM IODIDE; PROTEIN P25; PROTEIN P25ALPHA; TEMOZOLOMIDE; UNCLASSIFIED DRUG; VINCRISTINE;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TISSUE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFICACY; FLUORESCENCE HISTOCHEMISTRY; GLIA CELL; IMMUNOHISTOCHEMISTRY; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RAT; STRIATE CORTEX;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CARRIER PROTEINS; CELL DEATH; DACARBAZINE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; MICROTUBULE-ASSOCIATED PROTEINS; NEUROGLIA; NEURONS; NIMUSTINE; PIPERAZINES; PROPIDIUM; PYRIMIDINES; RATS; VINCRISTINE;

RATTUS;

EID: 84861460355     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-011-9300-9     Document Type: Article

References (89)

1. Agarwala SS, Kirkwood JM (2000) Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma. Oncologist 5:144-151 (Pubitemid 30238234)
2. Alcaraz A, Rey C, Concha A, Medina A (2002) Intrathecal vincristine: Fatal myeloencephalopathy despite cerebrospinal fluid perfusion. J Toxicol Clin Toxicol 40:557-561 (Pubitemid 34971207)
3. Back MF, Ang EL, Ng WH, See SJ, Lim CC, Chan S, Yeo TT (2007) Improved median survival for glioblastoma multiforme following introduction of adjuvant temozolomide chemotherapy. Ann Acad Med Singap 36:5-338
4. Boyle FM, Eller SL, Grossman SA (2004) Penetration of intraarterially administered vincristine in experimental brain tumor. Neuro Oncol 6:300-305 (Pubitemid 39429833)
5. Brandsma D, van den Bent MJ (2007) Molecular targeted therapies and chemotherapy in malignant gliomas. Curr Opin Oncol 19:598-605
6. Caeser M, Bonhoeffer T, Bolz J (1989) Cellular organization and development of slice cultures from rat visual cortex. Exp Brain Res 77:234-244 (Pubitemid 19232024)
7. Carloni S, Buonocore G, Balduini W (2008) Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury. Neurobiol Dis 32:329-339
8. de Boüard S, Christov C, Guillamo JS, Kassar-Duchossoy L, Palfi S, Leguerinel C, Masset M, Cohen-Hagenauer O, Peschanski M, Lefrancois T (2002) Invasion of human glioma biopsy specimens in cultures of rodent brain slices: A quantitative analysis. J Neurosurg 97:169-176 (Pubitemid 34693715)
9. Desjardins A, Quinn JA, Vredenburgh JJ, Sathornsumetee S, Friedman AH, Herndon JE, McLendon RE, Provenzale JM, Rich JN, Sampson JH, Gururangan S, Dowell JM, Salvado A, Friedman HS, Reardon DA (2007) Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas. J Neurooncol 83(1):53-60 (Pubitemid 46647165)
10. Dresemann G (2005) Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: A patient series. Ann Oncol 16:1702-1708 (Pubitemid 41510147)
11. Duntsch C, Divi MK, Jones T, Zhou Q, Krishnamurthy M, Boehm P, Wood G, Sills A, Moore BM (2006) Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma. J Neurooncol 77:143-152 (Pubitemid 44419748)
12. Eng LF, Ghirnikar RS, Lee YL (2000) Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000).NeurochemRes 25:1439-1451
13. Eyupoglu IY, Hahnen E, Trankle C, Savaskan NE, Siebzehnrubl FA, Buslei R, Lemke D, Wick W, Fahlbusch R, Blumcke I (2006) Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275. Mol Cancer Ther 5:1248-1255 (Pubitemid 43881317)
14. Gahwiler BH (1988) Organotypic cultures of neural tissue. Trends Neurosci 11:484-489
15. Gahwiler BH, Capogna M, Debanne D, McKinney RA, Thompson SM (1997) Organotypic slice cultures: A technique has come of age. Trends Neurosci 20:471-477 (Pubitemid 27421710)
16. Gaidys WG, Dickerman JD, Walters CL, Young PC (1983) Intrathecal vincristine. Report of a fatal case despite CNS washout. Cancer 52:799-801 (Pubitemid 13037640)
17. Groth-Pedersen L, Ostenfeld MS, Hoyer-Hansen M, Nylandsted J, Jaattela M (2007) Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine. Cancer Res 67:2217-2225 (Pubitemid 46424241)
18. Hagerstrand D, Hesselager G, Achterberg S, Wickenberg BU, Kowanetz M, Kastemar M, Heldin CH, Isaksson A, Nister M, Ostman A (2006) Characterization of an imatinib-sensitive subset of high-grade human glioma cultures. Oncogene 25:4913-4922 (Pubitemid 44201182)
19. Harada A, Teng J, Takei Y, Oguchi K, Hirokawa N (2002) MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction. J Cell Biol 158:541-549 (Pubitemid 34851712)
20. Hausmann R, Riess R, Fieguth A, Betz P (2000) Immunohistochemical investigations on the course of astroglial GFAP expression following human brain injury. Int J Legal Med 113:70-75 (Pubitemid 30123533)
21. Hoftberger R, Fink S, Aboul-Enein F, Botond G, Olah J, Berki T, Ovadi J, Lassmann H, Budka H, Kovacs GG (2010) Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis. Glia 58:1847-1857
22. Holdhoff M, Kreuzer KA, Appelt C, Scholz R, Na IK, Hildebrandt B, Riess H, Jordan A, Schmidt CA, Van Etten RA, Dorken B, le Coutre P (2005) Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor. Blood Cells Mol Dis 34:181-185 (Pubitemid 40250495)
23. Honig LS, Herrmann K, Shatz CJ (1996) Developmental changes revealed by immunohistochemical markers in human cerebral cortex. Cereb Cortex 6:794-806 (Pubitemid 26374304)
24. Ironside JW, Moss TH (2002) Astrocytic tumors Jackson DV Jr, Bender RA (1979) Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro. Cancer Res 39:4346-4349
25. Jackson DV Jr, Sethi VS, Spurr CL, McWhorter JM (1981) Pharmacokinetics of vincristine in the cerebrospinal fluid of humans. Cancer Res 41:1466-1468 (Pubitemid 11146783)
26. Jordan MA, Thrower D, Wilson L (1991) Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res 51:2212-2222
27. Jung S, Kim HW, Lee JH, Kang SS, Rhu HH, Jeong YI, Yang SY, Chung HY, Bae CS, Choi C, Shin BA, Kim KK, Ahn KY (2002) Brain tumor invasion model system using organotypic brainslice culture as an alternative to in vivo model. J Cancer Res Clin Oncol 128:469-476
28. Karaca M, Andrieu MN, Hicsonmez A, Guney Y, Kurtman C (2006) Cases of glioblastoma multiforme metastasizing to spinal cord. Neurol India 54:428-430 (Pubitemid 44870701)
29. Kilic T, Alberta JA, Zdunek PR, Acar M, Iannarelli P, O'Reilly T, Buchdunger E, Black PM, Stiles CD (2000) Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. Cancer Res 60:5143-5150
30. Kim JT, Kim JS, Ko KW, Kong DS, Kang CM, Kim MH, Son MJ, Song HS, Shin HJ, Lee DS, Eoh W, Nam DH (2006) Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas. Oncol Rep 16:33-39
31. Kochi M, Kuratsu J, Mihara Y, Takaki S, Seto H, Uemura S, Ushio Y (1993) Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2- chloroethyl)-1-nitrosou rea hydrochloride. Neurosurgery 33:817-823 (Pubitemid 23314171)
32. Kress GJ, Reynolds IJ (2005) Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures. Neurobiol Dis 20:639-645 (Pubitemid 41619340)
33. Kristensen BW, Noraberg J, Jakobsen B, Gramsbergen JB, Ebert B, Zimmer J (1999) Excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures. Brain Res 841:143-159 (Pubitemid 29441009)
34. Kristensen BW, Noraberg J, Thiebaud P, Koudelka-Hep M, Zimmer J (2001a) Biocompatibility of silicon-based arrays of electrodes coupled to organotypic hippocampal brain slice cultures. Brain Res 896:1-17 (Pubitemid 32244141)
35. Kristensen BW, Noraberg J, Zimmer J (2001b) Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures. Brain Res 917:21-44 (Pubitemid 32973195)
36. Kristensen BW, Noer H, Gramsbergen JB, Zimmer J, Noraberg J (2003a) Colchicine induces apoptosis in organotypic hippocampal slice cultures. Brain Res 964:264-278 (Pubitemid 36165151)
37. Kristensen BW, Noraberg J, Zimmer J (2003b) The GABAA receptor agonist THIP is neuroprotective in organotypic hippocampal slice cultures. Brain Res 973:303-306 (Pubitemid 36549168)
38. Kristensen BW, Blaabjerg M, Noraberg J, Zimmer J (2007) Longterm, repeated dose in vitro neurotoxicity of the glutamate receptor antagonist L-AP3, demonstrated in rat hippocampal slice cultures by using continuous propidium iodide incubation. Altern Lab Anim 35:211-221 (Pubitemid 46883161)
39. Kunkler PE, Kraig RP (1997) Reactive astrocytosis from excitotoxic injury in hippocampal organ culture parallels that seen in vivo. J Cereb Blood Flow Metab 17:26-43 (Pubitemid 27014905)
40. Laake JH, Haug FM, Wieloch T, Ottersen OP (1999) A simple in vitro model of ischemia based on hippocampal slice cultures and propidium iodide fluorescence. Brain Res Brain Res Protoc 4:173-184 (Pubitemid 29396417)
41. Leis JF, Stepan DE, Curtin PT, Ford JM, Peng B, Schubach S, Druker BJ, Maziarz RT (2004) Central nervous system failure in patients with chronic myelogenous leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with imatinib (STI-571). Leuk Lymphoma 45:695-698 (Pubitemid 38256028)
42. Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, Hojrup P, Moos T, Otzen D, Gai WP, Blumbergs PC, Jensen PH (2005) p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. J Biol Chem 280:5703-5715 (Pubitemid 40280050)
43. Mashiyama S, Katakura R, Takahashi K, Kitahara M, Suzuki J, Sasaki T (1990) Effects of X-irradiation alone and in combination with ACNU on human glioblastoma cells in vitro. Neurol Med Chir (Tokyo) 30:295-300 (Pubitemid 20270140)
44. Matsumura H, Ohnishi T, Kanemura Y, Maruno M, Yoshimine T (2000) Quantitative analysis of glioma cell invasion by confocal laser scanning microscopy in a novel brain slice model. Biochem Biophys Res Commun 269:513-520 (Pubitemid 30440332)
45. Milosevic A, Goldman JE (2002) Progenitors in the postnatal cerebellar white matter are antigenically heterogeneous. J Comp Neurol 452:192-203
46. Moore JK, Guan YL, Shi SR (1998) MAP2 expression in developing dendrites of human brainstem auditory neurons. J Chem Neuroanat 16:1-15 (Pubitemid 29049095)
47. Muller M, Rietschin L, Grogg F, Streit P, Gahwiler BH (1994) Selective degeneration of CA1 pyramidal cells by chronic application of bismuth. Hippocampus 4:204-209 (Pubitemid 24267883)
48. Nakagawa T, Kubota T, Ido K, Sakuma T, Matsuda K (2006) Gene expression profiles of 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3- nitrosourea (ACNU)-resistant C6 rat glioma cells. J Neurooncol 79:271-279 (Pubitemid 44363730)
49. Newlands ES, Stevens MF, Wedge SR, Wheelhouse RT, Brock C (1997) Temozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev 23:35-61 (Pubitemid 27273454)
50. Noraberg J, Zimmer J (1998) Ethanol induces MAP2 changes in organotypic hippocampal slice cultures. Neuroreport 9:3177-3182 (Pubitemid 28522332)
51. Noraberg J, Kristensen BW, Zimmer J (1999) Markers for neuronal degeneration in organotypic slice cultures. Brain Res Brain Res Protoc 3:278-290 (Pubitemid 29023528)
52. Oertel S, Krempien R, Lindel K, Zabel A, Milker-Zabel S, Bischof M, Lipson KE, Peschke P, Debus J, Abdollahi A, Huber PE (2006) Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec). Strahlenther Onkol 182:400-407 (Pubitemid 44025008)
53. Ostermann S, Csajka C, Buclin T, Leyvraz S, Lejeune F, Decosterd LA, Stupp R (2004) Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clin Cancer Res 10:3728-3736 (Pubitemid 38697606)
54. Palfi S, Swanson KR, de Boüardb S, Chretien F, Oliveira R, Gherardi RK, Kros JM, Peschanski M, Christov C (2004) Correlation of in vitro infiltration with glioma histological type in organotypic brain slices. Br J Cancer 91:745-752 (Pubitemid 39141635)
55. Patel M, McCully C, Godwin K, Balis FM (2003) Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates. J Neurooncol 61:203-207 (Pubitemid 36342297)
56. Petzer AL, Gunsilius E, Hayes M, Stockhammer G, Duba HC, Schneller F, Grunewald K, Poewe W, Gastl G (2002) Low concentrations of STI571 in the cerebrospinal fluid: A case report. Br J Haematol 117:623-625 (Pubitemid 34546037)
57. Pfeifer H, Wassmann B, Hofmann WK, Komor M, Scheuring U, Bruck P, Binckebanck A, Schleyer E, Gokbuget N, Wolff T, Lubbert M, Leimer L, Gschaidmeier H, Hoelzer D, Ottmann OG (2003) Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate. Clin Cancer Res 9:4674-4681 (Pubitemid 37336441)
58. Posmantur RM, Kampfl A, Taft WC, Bhattacharjee M, Dixon CE, Bao J, Hayes RL (1996) Diminished microtubule-associated protein 2 (MAP2) immunoreactivity following cortical impact brain injury. J Neurotrauma 13:125-137 (Pubitemid 26104497)
59. Qweider M, Gilsbach JM, Rohde V (2007) Inadvertent intrathecal vincristine administration: A neurosurgical emergency. Case report. J Neurosurg Spine 6:280-283 (Pubitemid 47066082)
60. Raymond E, Izbicka E, Soda H, Gerson SL, Dugan M, Von Hoff DD (1997) Activity of temozolomide against human tumor colonyforming units. Clin Cancer Res 3:1769-1774 (Pubitemid 27444716)
61. Reardon DA, Egorin MJ, Quinn JA, Rich JN, Gururangan S, Vredenburgh JJ, Desjardins A, Sathornsumetee S, Provenzale JM, Herndon JE, Dowell JM, Badruddoja MA, McLendon RE, Lagattuta TF, Kicielinski KP, Dresemann G, Sampson JH, Friedman AH, Salvado AJ, Friedman HS (2005) Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme. J Clin Oncol 23:9359-9368
62. Riol H, Fages C, Tardy M (1992) Transcriptional regulation of glial fibrillary acidic protein (GFAP)-mRNA expression during postnatal development of mouse brain. J Neurosci Res 32: 79-85
63. Russell JS, Brady K, Burgan WE, Cerra MA, Oswald KA, Camphausen K, Tofilon PJ (2003) Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. Cancer Res 63:7377-7383 (Pubitemid 37413479)
64. Sanganahalli BG, Joshi PG, Joshi NB (2006) NMDA and non-NMDA receptors stimulation causes differential oxidative stress in rat cortical slices. Neurochem Int 49:475-480 (Pubitemid 44189644)
65. Sankar A, Thomas DG, Darling JL (1999) Sensitivity of short-term cultures derived from human malignant glioma to the anti-cancer drug temozolomide. Anticancer Drugs 10:179-185 (Pubitemid 29141304)
66. Servidei T, Riccardi A, Sanguinetti M, Dominici C, Riccardi R (2006) Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation. J Cell Physiol 208:220-228 (Pubitemid 43849008)
67. Shingu T, Yamada K, Hara N, Moritake K, Osago H, Terashima M, Uemura T, Yamasaki T, Tsuchiya M (2003) Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoinositide 3-kinase inhibitor in human malignant glioma cells. Cancer Res 63:4044-4047 (Pubitemid 36917925)
68. Shiraishi A, Sakumi K, Sekiguchi M (2000) Increased susceptibility to chemotherapeutic alkylating agents of mice deficient in DNA repair methyltransferase. Carcinogenesis 21:1879-1883
69. Sims KB, Crandall JE, Kosik KS, Williams RS (1988) Microtubuleassociated protein 2 (MAP 2) immunoreactivity in human fetal neocortex. Brain Res 449:192-200
70. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB (2004) Identification of human brain tumour initiating cells. Nature 432:396-401 (Pubitemid 39551674)
71. Sioka C, Kyritsis AP (2009) Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol 63:761-767
72. Skjoerringe T, Lundvig DM, Jensen PH, Moos T (2006) P25alpha/ Tubulin polymerization promoting protein expression by myelinating oligodendrocytes of the developing rat brain. J Neurochem 99:333-342 (Pubitemid 44395155)
73. Song YJ, Lundvig DM, Huang Y, Gai WP, Blumbergs PC, Hojrup P, Otzen D, Halliday GM, Jensen PH (2007) p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Am J Pathol 171:1291-1303 (Pubitemid 47582902)
74. Sonoda Y, Matsumoto K, Kakuto Y, Nishino Y, Kumabe T, Tominaga T, Katakura R (2007) Primary CNS lymphoma treated with combined intra-arterial ACNU and radiotherapy. Acta Neurochir (Wien) 149:1183-1189 (Pubitemid 350132084)
75. Stevens MF, Hickman JA, Stone R, Gibson NW, Baig GU, Lunt E, Newton CG (1984) Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5, 1-d]-1,2,3,5-tetrazin-4(3 H)-one, a novel broad-spectrum antitumor agent. J Med Chem 27:196-201 (Pubitemid 14178871)
76. Stoppini L, Buchs PA,MullerD(1991)Asimplemethod for organotypic cultures of nervous tissue. J Neurosci Methods 37:173-182
77. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996 (Pubitemid 40349501)
78. Sugiyama S, Yamashita Y, Kikuchi T, Saito R, Kumabe T, Tominaga T (2007) Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models. J Neurooncol 82:41-47
79. Suzuki SO, Kitai R, Llena J, Lee SC, Goldman JE, Shafit-Zagardo B (2002) MAP-2e, a novel MAP-2 isoform, is expressed in gliomas and delineates tumor architecture and patterns of infiltration. J Neuropathol Exp Neurol 61:403-412 (Pubitemid 34537282)
80. Takayama N, Sato N, O'Brien SG, Ikeda Y, Okamoto S (2002) Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid. Br J Haematol 119:106-108 (Pubitemid 35176504)
81. Trog D, Moenkemann H, Breipohl W, Schueller H, Schild H, Golubnitschaja O (2006) Non-sufficient cell cycle control as possible clue for the resistance of human malignant glioma cells to clinically relevant treatment conditions. Amino Acids
82. Vairano M, Graziani G, Tentori L, Tringali G, Navarra P, Dello RC (2004) Primary cultures of microglial cells for testing toxicity of anticancer drugs. Toxicol Lett 148:91-94 (Pubitemid 38264524)
83. van Rijn J, Heimans JJ, van den Berg J, van der Valk P, Slotman BJ (2000) Survival of human glioma cells treated with various combination of temozolomide and X-rays. Int J Radiat Oncol Biol Phys 47:779-784 (Pubitemid 30317499)
84. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492-507
85. Wharton SB, Chan KK, Whittle IR (2002) Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas. J Clin Neurosci 9:165-169 (Pubitemid 34464588)
86. Wick A, Wick W, Hirrlinger J, Gerhardt E, Dringen R, Dichgans J, Weller M, Schulz JB (2004) Chemotherapy-induced cell death in primary cerebellar granule neurons but not in astrocytes: In vitro paradigm of differential neurotoxicity. J Neurochem 91:1067-1074 (Pubitemid 39587445)
87. Wolff JE, Berrak S, Koontz Webb SE, Zhang M (2008) Nitrosourea efficacy in high-grade glioma: A survival gain analysis summarizing 504 cohorts with 24193 patients. J Neurooncol 88:57-63
88. Yoshida D, Watanabe K, Noha M, Takahashi H, Teramoto A, Sugisaki Y (2003) Anti-invasive effect of an anti-matrix metalloproteinase agent in a murine brain slice model using the serial monitoring of green fluorescent protein-labeled glioma cells. Neurosurgery 52:187-196
89. Zhang ZG, Bower L, Zhang RL, Chen S, Windham JP, Chopp M (1999) Three-dimensional measurement of cerebral microvascular plasma perfusion, glial fibrillary acidic protein and microtubule associated protein-2 immunoreactivity after embolic stroke in rats: A double fluorescent labeled laser-scanning confocal microscopic study. Brain Res 844:55-66 (Pubitemid 29490952)